The latest price of Eltrombopag/Eltrombopag in Beacon, Bangladesh

Eltrombopag is an important thrombopoietin receptor agonist, widely used to treat chronic immune thrombocytopenia (ITP), thrombocytopenia caused by chronic hepatitis C, and severe aplastic anemia. As the demand for this drug increases, a variety of manufacturers have appeared on the market. Among them, eltrombopag produced by Bangladesh Beacon Pharmaceuticals has attracted the attention of many patients as a generic drug.

Eltrombopag of Bangladesh Becan is basically the same as the original drug in terms of ingredients and efficacy. However, because it is a generic drug, it has a certain price advantage over the original drug. According to the latest market information, Beacon Pharmaceutical's Eltrombopag is available in two specifications: 25 mg 28 tablets and 50 mg 28 tablets. Generally, the price of the 25mg specification is about more than one thousand yuan, while the price of the 50mg specification may be slightly higher, but the specific price will vary depending on the region, pharmacies and sales channels.

Patients using eltrombopag need to pay special attention to the fact that although generic drugs are attractive in terms of price, patients should still ensure that they are sourced legally and meet relevant quality standards when choosing them. As a well-known pharmaceutical company, Bangladesh Beacon's products have a good reputation in the international market, so many patients choose this brand of generic drugs. For those patients with limited financial conditions who hope to afford treatment, Becon's eltrombopag is a very good choice.

In addition, patients also need to undergo regular blood monitoring during the use of eltrombopag in order to understand their platelet levels and the efficacy of the drug in a timely manner. Adjust the dosage under the guidance of a doctor to ensure the safety and effectiveness of the treatment. Although generic drugs are less expensive, patients still need to follow professional medical advice to avoid unnecessary health risks.

Reference materials:https://go.drugbank.com/drugs/DB06210